Document is current
Any future updates will be listed below
-
Authors
Rouby, Jean-Jacques
Perbet, Sébastien
Quenot, Jean-Pierre
Zhang, Mao
Andreu, Pascal
Assefi, Mona
Gao, Yuzhi
Deransy, Romain
Lyu, Jie
Arbelot, Charlotte
An, Youzhong
Monsel, Antoine
Jing, Xia
Guerci, Philippe
Qian, Chuanyun
Malbouisson, Luiz
Morand, Dominique
Puybasset, Louis
Futier, Emmanuel
Constantin, Jean-Michel
Pereira, Bruno
,
Adam, Nicolas
Lecorre, Marine
Brisson, Hélène
Jabaudon, Matthieu
Chabanne, Russel
Collomb, Sylvia
Labruyère, Marie
Roudaut, Jean-Baptiste
Jacquier, Marine
Lyu, Shan
Ting, Yang
Birckener, Julien
Chenard, Laura
Longère, Benoît
Danin, Pierre-Eric
Payen, Jean-François
Wallet, Florent
Dexheimer, Felippe
- License Information
-
More Information
Article History
Received: 27 May 2024
Accepted: 11 November 2024
First Online: 26 November 2024
Declarations
:
: The study was approved by the Ethics Committee Sud-Est VI of Clermont-Ferrand, France and by the local Ethics Committee of each Chinese centre. The WIN-IN-WEAN study was registered at ClinicalTrials.gov with identifier number 1 NCT02123940.
: Not applicable.
: J-M. Constantin reports personal fees and non-financial support from Drager, GE Healthcare, Sedana Medical, Baxter, and Amomed; personal fees from Fisher and Paykel Healthcare, Orion, Philips Medical, and Fresenius Medical Care; and non-financial support from LFB and Bird Corporation, outside of the submitted work. All other authors declare that they have no competing interests.
